Hypoglycaemic activity of biosynthesized copper oxide nanoparticles in alloxan-induced diabetic Wister rats.

Maimuna Bello UmarAugustine Innalegwu DanielJimoh Oladejo TijaniRebecca Olufemi AkinleyeEnriquay SmithMarshall KeysterAshwil Klein

Published in: Endocrinology, diabetes & metabolism (2023)

The green synthesized CuO-NPs nanoparticles significantly reduced (p < 0.05) blood glucose levels in rats and other associated indices and could serve as drug lead in the treatment of diabetes.

Keyphrases

oxide nanoparticles
blood glucose
glycemic control
type diabetes
cardiovascular disease
drug induced
high glucose
diabetic rats
wound healing
blood pressure
oxidative stress
stress induced
smoking cessation